You have 9 free searches left this month | for more free features.

Angiogenesis

Showing 1 - 25 of 2,813

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)

Completed
  • Angiogenesis
  • Endometriosis
  • Leuprolide Acetate
  • Patra, Peloponnese, Greece
  • +1 more
Oct 27, 2023

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Covid19, Angiogenesis, Endothelial Dysfunction Trial in Independencia (Endothelial damage and angiogenic biomarkers)

Completed
  • Covid19
  • +3 more
  • Endothelial damage and angiogenic biomarkers
  • Independencia, Santiago, Chile
    Hospital Clínico de la Universidad de Chile
Jan 5, 2023

Peripheral Artery Disease Trial in Beijing (NL003, Placebo)

Recruiting
  • Peripheral Artery Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Wounds Trial (VAC® Therapy System)

Withdrawn
  • Wounds
  • VAC® Therapy System
  • (no location specified)
Jul 29, 2022

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Advanced

Not yet recruiting
  • Carcinoma, Hepatocellular
    • (no location specified)
    May 16, 2022

    Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

    Recruiting
    • Esophageal Neoplasms
    • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Apr 21, 2022

    Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)

    Completed
    • Neuroendocrine Tumors
    • One injection of 68Ga-NODAGA-E[c(RGDyK)]2
    • PET/CT
    • Copenhagen, Denmark
      Department of Clinical Physiology, Nuclear Medicine and PET, Rig
    Jun 28, 2022

    CD34 + Stem Cells and Biological Markers of Angiogenesis in

    Recruiting
    • Vasculopathy
    • Heart Transplant Failure
    • coronary CT angiography
    • Ljubljana, Slovenia
      Advanced Heart Failure and Transplantation Center, University Me
    Aug 2, 2022

    Myocardial Infarction, Acute, Myocardial Reperfusion, Chronic Ischemic Heart Disease Trial in Lausanne (68Ga-NODAGA-RGD PET/CT,

    Recruiting
    • Myocardial Infarction, Acute
    • +2 more
    • 68Ga-NODAGA-RGD PET/CT
    • 82-Rb PET/CT as part of standard care, not a comparator
    • Lausanne, Vaud, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Jun 11, 2022

    Von Willebrand Factor and Its Multimers on Angiogenesis

    Not yet recruiting
    • Von Willebrand Diseases
    • no intervention
    • Nantes, France
      CHU de Nantes
    Feb 17, 2022

    Nephrotoxicity Trial (Huaier Granule, VEGFR-TKIs)

    Not yet recruiting
    • Nephrotoxicity
    • (no location specified)
    Jan 5, 2023

    Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

    Not yet recruiting
    • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
    • Anlotinib Hydrochloride Capsule and Penpulimab
    • Beijing, Beijing, China
      YansongLin
    Sep 25, 2023

    NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 11, 2022

    Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

    Not yet recruiting
    • Carcinoma
    • +7 more
    • (no location specified)
    Nov 12, 2023

    Coronary Artery Disease Trial in Houston (Stem Cell Therapy, Control (plasma))

    Active, not recruiting
    • Coronary Artery Disease
    • Stem Cell Therapy
    • Control (plasma)
    • Houston, Texas
      Texas Heart Institute/Baylor St. Luke's Medical Center
    Apr 25, 2022

    Blood Flow MRI for Monitoring Brain Tumors

    Active, not recruiting
    • Brain Tumors
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jan 26, 2023

      Pathophysiology of Paget's Disease of Bone

      Active, not recruiting
      • Paget's Disease of Bone
        • Baltimore, Maryland
          Johns Hopkins University
        Oct 27, 2022

        Therapeutic Combination in Advanced or Metastatic Kidney Cancer

        Not yet recruiting
        • Renal Cell Carcinoma
        • +2 more
        • Blood collection
        • Tumour samples
        • Paris, France
        • +1 more
        Mar 9, 2022

        Biomarkers and Preeclampsia Outcomes

        Completed
        • Preeclampsia
          • Tunis, Tunisia
            Maternity Center of Tunis
          Aug 19, 2022

          Hematuria, Bladder Cancer Trial in Syracuse (Valproic Acid)

          Completed
          • Hematuria
          • Bladder Cancer
          • Valproic Acid
          • Syracuse, New York
            SUNY Upstate Medical University
          Oct 19, 2021

          Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

          Not yet recruiting
          • Small Cell Lung Cancer
          • +2 more
          • (no location specified)
          Nov 27, 2022

          Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

          Terminated
          • Ovarian Cancer
          • +21 more
          • Exercise Counseling
          • +5 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Oct 6, 2022

          Muscle Weakness, Angiogenesis Trial in Taipei (Interactive Hand Exercise Game, Soft ball exercise ( routine care))

          Not yet recruiting
          • Muscle Weakness
          • Angiogenesis
          • Interactive Hand Exercise Game
          • Soft ball exercise ( routine care)
          • Taipei, Taiwan
            Hsiao-Yean Chiu
          Aug 8, 2022

          Type 2 Diabetes Trial in Marseille (Liraglutide, Metformin or sulfonylurea)

          Completed
          • Type 2 Diabetes
          • Marseille, France
            Nutrition department, pole ENDO - Assistance Publique Hôpitaux M
          Jun 14, 2021